LIG4 and XLF/Cernunnos syndromes are rare autosomal recessive disorders with symptoms including microcephaly, severe growth delay, “bird-like” facial appearance, bony malformations, immunodeficiency and increased cellular sensitivity to IR (Çipe et al., 2014; Altmann and Gennery, 2016; Recio et al., 2019; Gerasimou et al., 2020). These shared features are due to loss of LIG4 and NHEJ1 function in encoding key NHEJ repair elements, impairing the final rejoining. The third component that makes up the final step of rejoining is XRCC4. Phenotypically, mutations in XRCC4 can induce microcephaly and growth delay (Guo et al., 2015; Rosin et al., 2015; Altmann and Gennery, 2016). Mutations in LIG4 are characterized by non-progressive microcephaly accompanied by immunodeficiency with or without neurodevelopmental delay (Altmann and Gennery, 2016). The evident prenatal microcephaly phenotype may arise due to ROS production in the fetal brain, inducing an accumulation of unrepaired DSBs (Altmann and Gennery, 2016; Lun et al., 2019).

Another hypothesis is that DSB formation may facilitate the expression of early response genes, which are markers of neural activity and insults (Hou and MacManus, 2002; Javed et al., 2018). In both cases, the neuronal population would be predisposed to apoptosis halting brain development without proper NHEJ function (Altmann and Gennery, 2016; Lun et al., 2019). Accordingly, Lig4 deficiency in mice is described as a cause of drastic cell death of newborn neurons and embryonic lethality, which may result from a sensitivity to unrepaired DSBs as observed in the human disease (Gao et al., 1998; Frank et al., 2000). Neuronal death was observed in the entire cortex; however, the lower cortical layers were more severely affected, indicating that Lig4 plays a role in the maintenance of a particular subset of neurons populating the radial extent of the cerebral cortex (Lun et al., 2019). Consistent with the role of LIG4 in DSB repair, different Lig4 models showed a marked sensitivity to IR as observed in syndromic patients (Adachi et al., 2001; Hentges et al., 2006; Gatz et al., 2011). In a LIG4 (Lig4 ^Y288C) mouse model analyzed for its susceptibility to IR, microcephaly was proposed to occur due to apoptosis resulting from persisting DSBs in the intermediate zone arising from the transit of damaged cells coming from the VZ and SVZ. This study also proposed that IR-induced apoptosis in the VZ and SVZ is partly ataxia telangiectasia mutated (ATM)-dependent, while in the intermediate zone, it is entirely ATM-dependent (Gatz et al., 2011). Signals generated by DNA damage occurrence, especially DSBs, are known to activate p53 through the ATM signaling (Canman et al., 1998; Frank et al., 2000).

Interestingly, in DDR-associated syndromes where patients display a mutation in the ATM component, microcephaly is not commonly observed, most likely because p53 cannot be activated (O’Driscoll and Jeggo, 2008). The activation of a p53-dependent apoptosis in response to DSB accumulation was suggested to underlie the Lig4 deficiency, as indicated by a rescue of neuronal death and embryonic lethality in Trp53 ^−/−; Lig4 ^−/− mice (Frank et al., 2000). Signs of premature neuronal differentiation or disrupted neuronal migration were not apparent, suggesting that the microcephalic phenotype was completely apoptosis-dependent (Gao et al., 1998; Lun et al., 2019).

Deleterious mutations in XLF/Cernunnos were identified for the first time in 2006, where all patients presented developmental defects including microcephaly (Ahnesorg et al., 2006; Buck et al., 2006). Curiously, in contrast to Lig4 KO mice, Xlf/Cernunnos KO mice are viable without gross developmental defects, limited to a few apoptotic cells in the embryonic brain (Vera et al., 2013; Abramowski et al., 2018), suggesting only minor DDR defects (Mokrani et al., 2020). However, radiosensitivity is still common in different Xlf-deficient models, such as mouse embryonic fibroblasts, pro-B cell lines and embryonic stem cells (Zha et al., 2007; Li et al., 2008b). Comparable to LIG4 syndromic embryos, mice deficient for both Xlf and Paxx, a recently identified component of the NHEJ process, presented embryonic lethality and extensive p53-dependent cell death, which was not the case for single Paxx or Xlf KO mice (Abramowski et al., 2018; Castañeda-Zegarra et al., 2019). It is believed that the difference between the human and mouse XLF phenotypes may be because different NHEJ and DDR factors such as ATM, H2A.X, 53BP1 and DNA-PKcs could partially compensate for the Xlf deficiency in mice, avoiding major developmental impairments (Gago-Fuentes and Oksenych, 2021). Yet, strikingly, another study by Bery et al. (2023), did show significant neurodevelopmental impairments in Xlf KO pups, with a concurrent mild microcephalic phenotype and intellectual disability, suggested to be caused by a lowered neuronal production and apoptosis of newly born neurons. Besides apoptosis, reduced proliferation and premature differentiation of Xlf KO RGCs could also be observed during the early stages of neurogenesis. The latter being a well-established mechanism contributing to microcephaly, was caused by an early switch from symmetric proliferative divisions to asymmetric neurogenic divisions, and considered as the primary cause for neuronal loss in Xlf KO mice (Mfossa et al., 2020; Bery et al., 2023). Recently, Xlf was pointed as an important factor for an efficient early stage development of neural progenitors in mice, as cells lacking Xlf presented reduced proliferative and self-renew capacity, that was intensified in cells lacking both Xlf and Paxx (Gago-Fuentes and Oksenych, 2021).

XRCC4 is an essential factor in NHEJ repair, which can directly bind to the DNA and form a stable complex with LIG4 stimulating its joining activity (Ruis et al., 2020). Homozygous missense mutations in XRCC4 can induce severe microcephaly (Shaheen et al., 2014; Bee et al., 2015; de Bruin et al., 2015; Guo et al., 2015; Murray et al., 2015; Rosin et al., 2015). However, XRCC4 deficiency does not entirely mimic LIG4 syndrome but also shares similarities with Cockayne syndrome, such as progressive neuronal degeneration, ataxia and no clinical immunodeficiency (Guo et al., 2015). In general, patients harboring XRCC4 mutations mainly show microcephaly, short stature, mental disabilities and facial dysmorphism (Saito et al., 2016). In vitro models have shown that fibroblasts established from XRCC4-deficient patients presented high sensitivity to IR, defective DSB repair and increased apoptosis after DNA damage (Guo et al., 2015; Murray et al., 2015; Rosin et al., 2015). In mice, Xrcc4 deficiency (Xrcc4 ^−/−) induces late embryonic lethality at the embryonic day (E) 16.5 which was attributed to massive p53-dependent apoptosis of newborn neurons resulting from increased numbers of unrepaired DSBs (Gao et al., 1998; Gao et al., 2000). Apoptosis of newborn neurons is a feature shared between Xrcc4 and Lig4 KO mice, but not the other NHEJ-deficient mouse models, and this drastic phenotype observed in Xrcc4 deficient mice may partly result from the associated loss of Lig4, as Xrcc4 is compulsory for its stabilization (de Villartay, 2015). In accordance, a recent study of a knock in Xrcc4 ^M61R mouse model avoiding Lig4 disruption showed rescued embryonic lethality and only a modest increase in apoptotic cells in the intermediate zone, indicating that microcephaly in XRCC4 syndrome may arise due to LIG4 destabilization (Roch et al., 2021).

Furthermore, it is known that NHEJ-related microcephalic syndromes can also be induced by mutations in the repair factor PNKP, which is mainly associated to two different syndromes: the microcephaly with seizures, hyperactivity, and developmental delay (MCSZ) and microcephaly associated with neurodegeneration and polyneuropathy (Shen et al., 2010; Poulton et al., 2013; Taniguchi-Ikeda et al., 2018). Among the NHEJ-related symptoms, seizures are an exclusive feature of MCSZ (Shen et al., 2010). PNKP is a bifunctional enzyme participating as a key factor in both BER by interacting with XRCC1 and NHEJ by interacting with XRCC4, participating in the resolution of SSBs and DSBs, respectively. Mutations in PNKP have been associated with DSBs accumulation (Weinf et al., 2011; Aceytuno et al., 2017; Dumitrache and McKinnon, 2017). Given the importance of PNKP in both pathways, it would be expected that its deficiency would impact beyond the brain as occurs in other repair-related syndromes such as NBS1 and LIG4, suggesting a role for PNKP in resolving specific types of DNA lesions in the human brain (Girard et al., 2004; Ben-Omran et al., 2005; Shimada et al., 2015). Strikingly, a recent study highlighted the essential role of Pnkp during mouse embryogenesis and neurogenesis, showing that both Pnkp deletion embryo-wide (Pnkp ^Sox2-cre ) or specifically in the brain (Pnkp ^Nes-cre ) induced lethality. Moreover, loss of Pnkp proved to be more severe when compared to Lig4 or Xrcc1 loss, indicating that at least in mice, Pnkp may be involved in the repair of a wider range of lesions, demonstrating an important difference between PNKP function in human and mouse (Shimada et al., 2015). In general, Pnkp loss has been shown to induce a thinning in the cerebral cortex, abundant p53-dependent apoptosis and impaired NPCs proliferation, leading to microcephaly (Shimada et al., 2015; Shin et al., 2021).

Mutations in the HR pathway are responsible for a range of microcephaly-related syndromes. The main HR effectors are the MRN proteins (MRE11-RAD50-NBS1), and mutations in this complex can lead to an interaction impairment failing to process DSB (Uziel et al., 2003). All patients carrying a mutation in NBS-1 present reduced brain size, that can have a progressive nature during the first months of life, showing that not all patients are microcephalic at birth (Hasbaoui et al., 2020). Similar to LIG4 and XLF/Cernunnos syndromes, besides marked microcephaly, “bird-like” facial features, developmental delay, immunodeficiency, radiosensitivity, and predisposition to cancer are present (Altmann and Gennery, 2016; Komatsu, 2016). At a cellular level, failure in HR repair due to NBS-1 dysregulation has been linked to genomic instability with impaired cell cycle kinetics and induction of apoptosis (Wan et al., 2013). Inactivation of Nbs-1 in the mouse brain (Nbn ^+/Δ6 ) led to decreased NPC proliferation and enhanced apoptosis of postmitotic neurons in the cerebellum through p53 activation (Frappart et al., 2005), while others showed that deletion of Nbs-1 in the mouse brain (Nbs1 ^fl/fl ; Atr ^+/fl ; NesCre+) mainly disrupts the VZ affecting only NPCs, resulting as well in decreased proliferation and apoptosis (Zhou et al., 2012). NPCs were also disturbed in NBS-1 patient-derived brain organoids, where premature neuronal differentiation was found, accompanied by impaired DDR, high levels of yH2A.X and consequent genomic instability. The premature differentiation of NPCs and increased neuronal apoptosis are suggested to be mainly governed by the delayed ATM-p53-mediated response often observed in NBS upon endogenous DNA damage, highlighting the role of p53 in the cell fate of NPCs (Martins et al., 2022).

Seckel syndrome (SS) is a rare disorder occurring due to mutations in more than 10 genes, classifying SS as a genetically heterogeneous disease. These genes are mainly associated with the DDR or centriole formation, and syndromic patients are characterized by drastic microcephaly with mental disability, dwarfism, and growth retardation (Panigrahi et al., 2009; Kirtay et al., 2021). In 2000, ATR was the first gene to be mapped to chromosome 3q22.1-q24 (SCKL1) in two Pakistani families (Panigrahi et al., 2009). As mentioned before, ssDNA is one of the products resulting from DSB processing during HR, leading to the ATR activation (Krajewska et al., 2015). Besides maintaining replication fork stability, ATR coordinates cell cycle checkpoint activation, supporting genome integrity (Llorens-Agost et al., 2018). In vitro studies demonstrated an impaired DDR in cell lines established from severely affected individuals, mainly showing reduced phosphorylation of H2A.X, p53, and Chk1, failure to start the G2/M checkpoint, and centrosome deficiencies (O’Driscoll et al., 2003; Alderton et al., 2004). In mice, the replicative stress was further investigated, demonstrating a dramatic accumulation of γH2A.X and activated p53 throughout the embryo, culminating in increased apoptosis, aggravated by loss of p53, and eventually microcephaly. The observed high sensitivity to replicative stress in the embryonic brain could be explained by the exponential replicative expansion in the first days of life (O’Driscoll and Jeggo, 2008; McKinnon, 2009; Murga et al., 2009).

Besides the role of BRCA2 as a tumor suppressor and cell cycle regulator, it is also a key component of the HR repair pathway (Prakash et al., 2015). BRCA2 directly interacts with RAD51 through its carboxyl terminus, allowing its translocation to DSB processing sites facilitating the DNA damage repair (Holloman, 2011). Mutations in BRCA2 leading to a complete loss of function cause embryonic lethality in both humans and mice. On the other hand, biallelic hypomorphic mutations in BRCA2 have been associated to hypersensitivity to DNA damage and FA leading to the manifestation of microcephaly in affected patients (Weinberg-Shukron et al., 2019; Kennedy and D’Andrea, 2005; Frappart et al., 2007; Sharan et al., 1997). In mice, inactivation of Brca2 (Brca2 ^LoxP/LoxP; Nestin-cre) led to increased levels of yH2AX foci followed by apoptosis in both NPCs and early post-mitotic neurons, that culminates in defective neural development leading to microcephaly due to genotoxic stress. p53 inactivation could rescue the reduced brain size, however some cell death could still be observed in the cerebellum of Brca2 ^Nes-cre; Trp53 ^−/− mice indicating that apoptosis is partially independent of p53 (Frappart et al., 2007).

The first Microcephalin 1 (MCPH1) mutation was reported in 2002 in two Pakistani families (Jackson et al., 2002). Until now, 14 additional mutations have been described, all of them leading to MCPH1, an uncommon heterogeneous disorder affecting brain development, and implicated in ATM/ATR-dependent DDR, HR, and G2/M checkpoint arrest. All these mutations are located in exons 1 to 6, and mutations found in exons 2 and 3, which encode the N-terminal BRCT domain, indicate an essential function of this domain in the neurodevelopment (Liu et al., 2016). Further reports have shown different outcomes depending on the type of mutation. A mild cellular and clinical phenotype is observed in the case of a missense mutation.

In contrast, mental disabilities and mild microcephaly are seen in the case of larger mutations affecting the six exons of MCPH1 (Trimborn et al., 2005; Garshasbi et al., 2006; Mahmood et al., 2011). Individuals presenting mutations in the MCPH1 gene have a head circumference below the mean, mental disabilities, developmental delays, impaired language skills and infertility, and premature chromosome condensation is considered a hallmark of this disease (Alderton et al., 2006; Wood et al., 2007; Gruber et al., 2011; Liu et al., 2021; Papoulidis et al., 2022). Mutations in MCPH1 are proposed to link impaired DDR and MCPH occurrence (Mahmood et al., 2011). Over the past years, different genetic mouse models have been developed aiming to understand the role of MCPH1. The first Mcph1 KO model (exon 2 deletions) survived until adulthood but presented sterility and impaired growth, with only 80% of the body weight compared to WT mice (Liang et al., 2010). Mice with an insertion between exons 3 and 4 exhibited a 15% reduction in brain weight without showing general growth retardation (Chen et al., 2013). In yet another model, a deletion of exons 4 and 5 resulted in a reduced brain weight, increased apoptosis in the VZ and SVZ, and thinning of the neocortex. A similar cortex thinning and overall reduced brain size were also observed in Mcph1 mutant mice with a deletion of the N-terminal BRCT domain, accompanied by NPC depletion and premature differentiation (Trimborn et al., 2010). However, these manifestations were not observed after deletion of the C-terminal BRCT domain, suggesting that the DDR remained unaffected in that case. Thus, N-terminal BRCT appears to be required for a proper DDR initiation, as well as for ensuring an appropriate size of brain and regulating NPC fate (Trimborn et al., 2010; Liu et al., 2021). MCPH1 has been recognized as an essential player of the HR pathway through direct interaction with BRCA2 and RAD51, enabling the RAD51/BRCA2 complex to bind to damaged strands (Chang et al., 2020). Moreover, Zhou et al. (2013) also investigated the sensitivity of Mcph1 KO mice to IR, revealing massive apoptosis specifically in NPCs and their immediate progeny, reinforcing the notion that a proficient DDR is crucial during early neurogenesis. Altogether, these studies show that MCPH1 is essential for various biological processes, including DNA damage repair, chromosome condensation, and brain development.

The INO80 gene was identified as another candidate for microcephaly and it has been shown to play a role in the HR pathway, mediating the removal of histone subunit H2A.Z, and exchanging RPA for RAD51, which are crucial steps in the DSB repair (Shaheen et al., 2014; Alatwi and Downs, 2015; Alazami et al., 2015; Morrison, 2017; Keil et al., 2020). Ino80 conditional KO mice further revealed DSB accumulation, particularly in NPCs, triggering p53 target gene activation and apoptosis, culminating in microcephaly. Different outcomes to the loss of Ino80 could be observed. Ino80 deletion during NPCs symmetric divisions led to DNA breaks, which was not observed for asymmetric divisions. These findings are consistent with the possibility that activation of HR is not preferable during asymmetric divisions, being selectively activated during symmetric divisions (Keil et al., 2020).

NER deficiencies are implicated in various autosomal recessive human disorders, including XP, CS, and TTD, which exhibit photosensitivity, skin cancer, developmental and neurological abnormalities (Vermeulen and Fousteri, 2013). Although impaired NER can explain skin sensitivity, the direct connection between UV-induced defects in neurological disorders remains unclear.

Xeroderma Pigmentosum is a rare autosomal disorder that arises from mutations in one of seven XP genes (XPA through -XPG), and the XP variant gene (Brooks, 2002). Approximately 25% of individuals with Xeroderma Pigmentosum have neurologic manifestations, including acquired microcephaly and progressive cognitive impairment. XP-A, XP-B, XP-D, XP-G, and XP-F patients have defects in NER and translesion DNA synthesis processes, making them more susceptible to neurological symptoms (Fassihi et al., 2016). In animal models, research on Xpa‐deficient murine neuroblasts has revealed disruptions in cellular mobility, providing a plausible mechanistic link to perturbed neurogenesis and the consequent manifestation of microcephaly (Takeuchi et al., 2023).

Cockayne syndrome is a rare autosomal recessive disorder with elevated UV sensitivity, severe growth impairment, premature aging, and progressive nervous system abnormalities (Jaarsma et al., 2013). The neurological symptoms include substantial growth defects, neuronal loss, calcification, mental retardation, and postnatal microcephaly. The severe cerebral white matter atrophy observed in CS patients is the cause of microcephaly, which is considered a cardinal feature of this syndrome (Baraitser et al., 1983; Nance and Berry, 1992; Spivak, 2004). Genetically, CS arises from mutations in five specific genes: CSA, CSB, XPB, XPD, and XPG (Jaarsma et al., 2013).

While murine Csa and Csb deficiencies result in only mild neurodegenerative changes, recent studies in human NPCs demonstrate that CSB suppression impairs neuronal differentiation, reduces microtubule-associated protein 2 (MAP2), disrupts cell polarization, and induces neuronal loss via DNA damage accumulation (Scheibye-Knudsen et al., 2012; Ciaffardini et al., 2014). These findings underscore CSB’s specific role in human postnatal neurogenesis, potentially explaining certain neurological features, such as microcephaly, in Cockayne syndrome patients (Ciaffardini et al., 2014).

Trichothiodystrophy is a clinically and genetically heterogeneous group of rare autosomal recessive disorders characterized by brittle hair, and scaly skin, including neurological defects (Price et al., 1980). It is associated with genetic mutations in the subunits of TFIIH, such as ERCC2/XPD, ERCC3/XPB, and GTF2H5/TTDA/p8, as well as in MPLKIP/C7ORF11, RNF113A, GTF2E2, CARS1, TARS1, AARS1, and MARS1 genes (Theil et al., 2014; Nakabayashi et al., 2005; Zhou et al., 2018; Corbett et al., 2015; Kuschal et al., 2016; Theil et al., 2017; Kuo et al., 2019; Theil et al., 2019; Botta et al., 2021; Iben et al., 2002). A comprehensive examination of the literature involving 112 individuals diagnosed with trichothiodystrophy revealed neurological abnormalities in a significant proportion of cases (86%) (Faghri et al., 2008). These individuals exhibited various neurological complications, including intellectual impairment (75%), developmental delay (68%), microcephaly (50%), impaired motor control or psychomotor retardation (37%), ataxia (26%), demyelination of cortical neurons (14%), and cerebral atrophy (4%).

Fanconi Anaemia is a rare genetic disease characterized by impaired cell cycle regulation and DNA repair mechanisms (Moreno et al., 2021). The FA-BRCA pathway (FA pathway), involving various FANC genes, is essential for DNA damage response, particularly in repairing DNA inter-strand crosslinks, resulting in genome instability characterized by chromosomal breaks and radial figures (Su and Huang, 2011). In brain development, the FA pathway ensures genomic integrity and NPCs survival during replicative stress (Sii-Felice et al., 2008; Forrer Charlier and Martins, 2020). While BRCA1 contributes significantly to inhibition of apoptosis in NPCs (Pao et al., 2014), FANCA is necessary for the maintenance and survival of neural stem cells (NSCs), contributing to the proper brain development (Sii-Felice et al., 2008).

Genetically, FA is characterized by the defects in one or multiple of the 23 FANC proteins (FA subtype proteins) from FANCA through FANCY The disease follows autosomal recessive pattern with 21 genes involved, including: FANCA, FANCC, FANCD1/BRCA2, FANCD2, FANCE, FANCF, FANCG/XRCC9, FANCI, FANCJ/BRIP1, FANCL, FANCM, FANCN/PALB2, FANCO/RAD51C, FANCP/SLX4, FANCQ/ERCC4, FANCS/BRCA1, FANCT/UBE2T, FANCU/XRCC2, FANCV/REV7 and FANCW/RFWD3, FANCY/FAP100 (Ceccaldi et al., 2016; Niraj et al., 2019; Lipton et al., 2020; Moreno et al., 2021; Repczynska et al., 2022). Additionally, FA can also exhibit an X-linked recessive pattern caused by FANCB (Meetei et al., 2004), and de novo autosomal dominant pattern by FANCR/RAD51 (Ameziane et al., 2015; Wang et al., 2015; Repczynska et al., 2022).

In human, mutations in FANCA, FANCC, and FANCG genes account for 80 to 90 percent of FA cases, with FANCA mutation being detected in 70% of cases (Moreno et al., 2021). These mutations have been associated with an increased incidence of CNS abnormalities, including ectopic neurohypophysis, adenohypophysis hypoplasia, platybasia, and other abnormalities in the midline of the skull base and posterior fossa (Pavlakis et al., 1992; Deepak Amalnath et al., 2012).

A study by Shahin et al. (2023) revealed a direct association between the FA pathway and the Ncf1/Igfbp2 signalling in regulating NSC fate. They found that inhibiting Brca1 DNA repair genes in murine Ncf1 ^−/− and Igfbp2 ^−/− NPCs resulted in the exit from self-renewal to neurogenesis, akin to WT NSCs. Conversely, Fanca overexpression in WT NSCs reduced neurosphere formation, emphasizing the FA pathway’s role in NSC lineage commitment and neurosphere formation. In another study, Fanca ^−/− and Fancg ^−/− mouse embryos demonstrated microcephaly as a result of elevated apoptosis in proliferating NPCs, driven by increased chromosomal instability. Both embryonic and adult Fanconi murine NSCs showed reduced in vitro self-renewal capacity and decreased neuron production, underscoring the FA pathway’s importance in regulating neural progenitor self-renewal, proliferation during embryogenesis, and adult brain homeostasis (Sii-Felice et al., 2008).

Disruptions in brain size can also be caused by mutations in genes participating in mitosis regulation (Bartkowska et al., 2018; Javed et al., 2018). Among these are KNL1, ASPM, and CITK, which are especially required during neurogenesis being extensively expressed in the VZ and SVZ, are known to induce the accumulation of DNA lesions and microcephaly when defective (Silver et al., 2010; Mao et al., 2016; Shi et al., 2019).

Mutations in the kinetochore scaffold 1 (KNL1) gene, also known as MCPH4, have been described (Fitze et al., 1999; Genin et al., 2012; Saadi et al., 2016; Szczepansk et al., 2016; Zarate et al., 2016). This was endorsed by further studies demonstrating highest expression of KNL1 in the fetal brain at the 9th gestational week, which marks the onset of neurogenesis, and sharply decreasing after birth (Shi et al., 2017). In hESC-derived NPCs, a KNL1 mutation (KNL1 ^{c.6125G > A} ) has been associated to aneuploidy, reduced proliferation, premature differentiation, apoptosis, and an abrogated spindle assembly checkpoint (SAC), culminating in microcephaly (Javed et al., 2018). It is known that KNL1 plays an important role during mitosis participating in proper kinetochore assembly, chromosome alignment and SAC signaling (Ahn and Jun, 2007). Thus, when KNL1 is defective, the SAC can be prematurely deactivated, leading to segregation errors and consequently numerical aneuploidy (Silió et al., 2015). Previous studies have reported that altered SAC can cause microcephaly (Genin et al., 2012; Mirzaa et al., 2014). However, recent findings have demonstrated that Knl1-induced microcephaly in mice (Knl1 ^fl/fl ; hGFAP-Cre) is not a direct result of aneuploidy, but from the generation of missegregated chromosomes carrying DNA damage in the form of DSBs after SAC disruption. These lesions triggered p53-dependent apoptosis, leading to a robust removal of damaged NPCs through microglial phagocytosis (Shi et al., 2019). However, defects in centrosomal proteins can impair brain development without leading to DSBs accumulation, highlighting the differences between SAC disruption and centrosomal defects in microcephaly (Insolera et al., 2014; Shi et al., 2019).

Abnormal spindle-like microcephaly-associated (ASPM) localizes to spindle poles during mitosis. It is arguably the most well-known centrosomal gene causative of microcephaly, as recessive mutations cause the MCPH5 syndrome, which is the most prevalent form of MCPH, characterized by severe microcephaly (Létard et al., 2018). Mechanistically, ASPM regulates mitotic spindle formation and localization during neurogenesis, and ASPM mutations lead to several mitotic defects in NECs, including abnormal spindle orientation leading to a reduction in the pool of these progenitors (Fish et al., 2006). Furthermore, ASPM was found to promote HR-mediated repair of DSBs following replication stress and UV irradiation (Xu et al., 2021; Wu et al., 2022). Additionally, while ASPM dysfunction induces DNA damage and postnatal p53-dependent apoptosis of cerebellar progenitors in mice, KO of ASPM in the ferret has been shown to induce premature displacement of ventricular RGCs to the outer SVZ, suggesting that ASPM regulates cortical expansion (Williams et al., 2015; Johnson et al., 2018; Zhou et al., 2020).

Another MCPH-related protein that localizes to the spindle poles during mitosis is the multi-domain citron kinase (CITK). It has recently also been linked to a syndromic type of microcephaly in humans, known as MCPH17, which is marked by reduced brain size, intellectual disability ranging from moderate to severe, short stature, and renal agenesis (Harding et al., 2016). CITK, together with ASPM controls spindle orientation and cytokinesis and its absence results in perturbed spindle orientation and neurogenic cytokinesis of neuroepithelial progenitors (Basit et al., 2016). However, CITK is also responsible for recruiting BRCA1 to DNA damage sites (Iegiani et al., 2022), and interacts with proteins implicated in the HR pathway such as KIF4A and CDKN1B, indicating that it could also participate in the DDR (Harding et al., 2016; Bianchi et al., 2017). In mice, Citk deficiency is associated with cytokinesis defects, DSBs accumulation, and p53-dependent apoptosis, and overall impaired mouse neurogenesis leading to microcephaly (Di Cunto et al., 2000; Sarkisian et al., 2002; Bianchi et al., 2017; Iegiani et al., 2022).

Neurodevelopmental deficits have also been found in patients presenting mutations in the exon junction complex (EJC) (Laumonnier et al., 2010; Albers et al., 2012; Nguyen et al., 2013), a regulator of mRNA metabolism of which the core complex is constituted by EIF4A3, MAGOH, RBM8A and CASC3 proteins (Gerbracht et al., 2020). The first evidences associating the EJC and brain development came from studies implicating Magoh in the occurrence of microcephaly in mice (Silver et al., 2010). Centrosomal defects and extensive DNA damage leading to cell death could be observed as a result of prolonged mitosis, demonstrating that Magoh is a crucial regulator of NSC division being required for proper orientation of the mitotic plane and cell fate determination (Silver et al., 2010; Mao et al., 2016). Indeed, the generation of a conditional KO revealed that NSC-specific depletion of Magoh induces microcephaly, suggesting that NSC dysfunction and altered mitosis may influence neuronal and stem cell production (McMahon et al., 2014). In general, Magoh deficient mice show decreased thickness of all cortical layers, NSC depletion, reduced number of intermediate progenitors, and apoptosis of newborn neurons, all of which lead to microcephaly (Silver et al., 2010; McMahon et al., 2014; Pilaz et al., 2016).

The RBM8A gene, also known as Y14, is another essential neurogenesis regulator, is located on 1q21.1 and microdeletions within this region are associated to a wide range of human diseases, including microcephaly (Brunetti-Pierri et al., 2008; Mao et al., 2015). In mice, depletion of Rbm8a revealed a microcephaly phenotype similar to the one observed in Magoh. Here, the neuronal loss is mainly observed in upper cortical layers, and reduced proliferation accompanied of premature differentiation of NPCs were found (Mao et al., 2015; Zou et al., 2015; Mao et al., 2016). Rbm8a deficiency can also impair ciliogenesis, provoke centrosome aberrations and cause DNA damage, inducing p53 activation (Silver et al., 2010; Chuang et al., 2019; Kwon et al., 2021). Besides mRNA metabolism, a role for RBM8A in the DDR has recently been described, as it was shown to interact with Ku70/80 (Chuang et al., 2019; Tsai et al., 2021).

Similarly to Rbm8a and Magoh, Eif4a3-deficient mice presented microcephaly accompanied with NSC mitotic defects, DNA damage, and extensive neuronal p53-dependent apoptosis. The p53 activation is described as a major mechanism implicated in EJC-induced microcephaly, as it rescues the brain size phenotype in all Eif4a3, Magoh and Rbm8a mutants when it is inactive (Mao et al., 2016; Bowen and Attardi, 2019; Chuang et al., 2019). As summarized here, EJC components can impair brain development by different mechanisms, including spontaneous DNA damage generation, which is partially responsible for the occurrence of microcephaly in these models.

The primary mechanism by which IR can injure cells is mainly through DNA damage (Santivasi and Xia, 2014). IR-induced DNA damage can be either direct by causing DNA breaks, especially DSBs, or indirect by producing free radicals, leading to several injuries such as AP sites, SSBs and DSBs. These lesions can induce cell death if not correctly repaired (Borrego-Soto et al., 2015). Despite the indisputable importance of IR use for clinical purposes, many health consequences have been attributed to IR, primarily when the exposure occurs during the embryonic development (Inouye, 1995; Verreet et al., 2016a). Epidemiological studies based on the outcomes of the nuclear bombings of Hiroshima and Nagasaki have shown that exposure to moderate and high doses of IR, especially between weeks 8 and 15 of pregnancy, can have severe consequences, especially for the developing brain inducing long-term neuronal effects (Otake and Schull, 1993; Otake and Schull, 1998). Early exposure to IR has been associated with microcephaly, dementia, affected memory and learning skills, and an increased risk for seizures (Verreet et al., 2016b; Mouton et al., 2021).

Rodent models have been mostly used to supplement human data to elucidate how IR affects brain development. Different studies of in-utero irradiated mice showed a reduction in the brain size with a dose threshold of around 0.3 Gy at the onset of neurogenesis (Verreet et al., 2016a; Shimada et al., 2016; Mfossa et al., 2020). When analyzing mouse embryos irradiated at embryonic day (E) 12 onwards, the VZ and SVZ are the central affected brain regions with NPCs undergoing apoptosis, a mechanism underlying microcephaly in these models (Lee et al., 2001; Gatz et al., 2011; Roque et al., 2012; Saha et al., 2014). Accordingly, a reduced expression of the ASPM gene in the VZ of E12 irradiated mice was described, inducing the switch from proliferative to neurogenic divisions causing microcephaly through a reduction in the number of NPCs in the VZ (Fujimori et al., 2008). Mitotic defects were also reported as another mechanism underlying IR-induced microcephaly, as mouse embryos irradiated at E13.5 presented centrosomal aberrations culminating in NPC depletion (Shimada et al., 2016). Besides apoptosis and mitotic defects, p53-dependent premature differentiation of NPCs was proposed as another IR-dependent mechanism leading to microcephaly, this time in mice irradiated at E11, an early time point of neurogenesis (Mfossa et al., 2020). Of interest, another study in mouse embryos irradiated at E11 showed that the cortical plate constituted of differentiating neurons was the most affected region (Verreet et al., 2016a), contradicting the hypothesis that proliferative cells are the most radiosensitive ones (Bergonié and Tribondeau, 1959; Verreet et al., 2015).

Despite the indisputable relevance of the previously mentioned mechanisms, the DNA damage resulting in p53-dependent apoptosis is believed to be the main factor leading to microcephaly after radiation exposure (Verheyde et al., 2006; Quintens et al., 2015; Verreet et al., 2015; Mfossa et al., 2020), and as well in many other developmental syndromes (Bowen and Attardi, 2019) as discussed here. Indeed, it is known that IR induces a dose-dependent DSB foci formation in the cerebral cortex of mice, accompanied by a cell cycle arrest at the G2/M checkpoint and p53-dependent apoptosis (Gatz et al., 2011; Saha et al., 2014; Mfossa et al., 2020). Interestingly, p53 is highly expressed in the embryonic brain compared to the adult brain. While it regulates NPC differentiation (Mendrysa et al., 2011), it seems to be dispensable for normal brain development (Wang et al., 2009), even though a small fraction of Trp53 null mice display exencephaly (Armstrong et al., 1995; Sah et al., 1995). Nevertheless, in the case of a p53 hyperactivation in response to DSB formation following irradiation during embryogenesis, p53 can induce massive apoptosis of NPCs and reduced proliferative states in the developing brain culminating in a range of developmental defects including microcephaly (Bowen and Attardi, 2019; Mfossa et al., 2020).

To date, several viral infections have been linked to microcephaly during pregnancy. For instance, the cytomegalovirus, herpes simplex virus, rubella virus, and Zika virus (ZIKV) can infect the fetus by crossing the placenta, and also present a tropism for the brain, being commonly associated with reduced brain size (Devakumar et al., 2018). Cytomegalovirus is known to alter the progenitor pool fate, induce premature differentiation, and also impair neuronal differentiation through PPARɣ activation (Devakumar et al., 2018; Sun et al., 2020). Herpes simplex virus infection has been linked to NPC pool depletion and impaired differentiation (Krenn et al., 2021). The mechanisms by which Rubella virus lead to microcephaly is still unclear (Devakumar et al., 2018). Here we focus on the most notable virus linked to microcephaly in newborns, the ZIKV.

The ZIKV was first described in Africa in 1947, and subsequent cases were reported in other countries. ZIKV is transmitted through the bite of the infected Aedes aegypti mosquito, and in most cases, the infection is not alarming. However, accumulating evidence has shown that infection during pregnancy can lead to fetal genetic neuroabnormalities (Antoniou et al., 2020). It is known that a single aminoacid substitution in prM, one of the ten ZIKV-encoded proteins, is responsible for a change in the virus tropism, specifically targeting the brain (Saade et al., 2020). Despite the fact that ZIKV neurotropism has been known since its discovery, it was not associated to developmental disorders until a few years ago (Ledur et al., 2020). In 2015, ZIKV was declared a Public Health Emergency in Brazil, strongly linked to devastating effects on fetal neurodevelopment, leading to a reduction in brain size (Kindhauser et al., 2016). In response to this outbreak, widespread efforts have been made to understand how ZIKV infection may induce microcephaly. It is known that the interaction between viruses and their hosts can often induce the evolutionarily response to DNA damage, that can be activated upon viral interaction with the host DNA or by ROS production during viral replication (Luftig, 2014; Ryan et al., 2016). Here, we highlight the ZIKV-induced DNA damage and its relation with microcephaly.

It is a consensus in the literature that ZIKV can directly infect human NPCs in vitro, mimicking microcephaly (Wen et al., 2017). Different studies revealed an impaired cell cycle progression causing a reduction in human NPC proliferation marked by a reduced expression of the proliferation markers Edu and Ki67, a reduced cell density and cell cycle arrest in S-phase (Cugola et al., 2016; Souza et al., 2016; Tang et al., 2017). These findings were confirmed by different studies using mouse models, that found a reduction in the thickness of the brain cortex and in the number of mitotic cells in the VZ and SVZ, centrosomes amplification and cell cycle arrest in S-, G1- or G2- phases (Li et al., 2016; Nguyen et al., 2016; Shao et al., 2016; Wu et al., 2016). Besides cell cycle impairments, premature neuronal differentiation (Gabriel and Gopalakrishnan, 2017; Saade et al., 2020) and cell death (Wen et al., 2017) are also frequently found to contribute to ZIKV-induced microcephaly, although so far only the latter has been clearly shown to be associated with DNA damage induction. Post-mortem analysis of fetal brain tissues revealed cortical thinning and extensive apoptosis (Driggers et al., 2016), and different studies using human iPSC-derived NPC, brain organoids and mouse models reaffirmed these findings, showing increased cell death marked by caspase 3 activation in the neocortex and DNA fragmentation leading to a reduction in the NPC pool (Cugola et al., 2016; Garcez et al., 2016; Qian et al., 2016; Miner et al., 2016; Shao et al., 2016; Souza et al., 2016; Wu et al., 2016; Tang et al., 2017). The effects of ZIKV on astrocytes, a cell type with the highest infection rate in the brain, were also demonstrated showing mitochondrial damage and ROS production leading to DNA damage followed by cell death (Ledur et al., 2020).

It is known that virus-induced DNA damage can generate lesions such as SSBs and DSBs (Ryan et al., 2016). RNA-seq analysis showed BRCA1 and MRE11A upregulation in neurospheres infected with ZIKV, and an increased γH2A.X signal has also been demonstrated in NPCs, both indicating a possible DDR to DSBs after ZIKV infection (El Ghouzzi et al., 2016; Garcez et al., 2017). Further studies have validated these findings showing that ZIKV can induce the DDR upon DSBs recognition contributing to NPC depletion (Hammack et al., 2019). Hammack et al. (2019) reported ATM/Chk2 pathway activation in response to DSBs in infected NPCs, and also showed inhibited cell cycle progression through S-phase which seems to provide a beneficial environment to Uganda and Puerto Rico ZIKV strains replication and thereby restricted NPC proliferation. Of interest, while both strains induced cell death in NPCs, in NSCs a distinct infection pattern was found for both strains. In particular, the Uganda strain increased yH2A.X levels, whereas the Puerto Rico strain arrested cell cycle progression through elevated p53 levels. It was observed that NSCs infected by the Puerto Rico strain when stimulated to differentiate into progenitors presented higher susceptibility to cell death (Devhare et al., 2017). In the Brazilian ZIKV strain, Cyclin E downregulation and Cyclin-dependent kinase inhibitor 1A upregulation have been pointed as another mechanism by which ZIKV induces cell cycle arrest and reduces the NPC pool (Garcez et al., 2017). Interestingly, NSC-derived NPCs infected with the Uganda strain presented less viral replication when compared to parental NSCs, which can partly explain the severity of ZIKV infection during early brain development (Devhare et al., 2017). Recently, a link between PNKP inhibition and ZIKV infection has been identified. Here, PNKP depletion led to DNA damage accumulation in NPCs after ZIKV infection, failure to activate the DNA damage checkpoints Chk1 and Chk2 and cytoplasmic accumulation of CycA/CDK1 complexes resulting in mitotic catastrophe (Rychlowska et al., 2022).

Global genetic analyses trough RNA-seq revealed a downregulation of cell cycle-related and DDR pathways, including many p53-dependent genes, upon ZIKV infection. NER, MMR, HR, ATR and G2/M checkpoint were found downregulated after infecting human neural crest cells and neurons with the Asian strain, while a couple of downregulated genes implicated in HR, NHEJ and FA pathways were found after infection of NPCs with the Asian and African strains (El Ghouzzi et al., 2016; Zhang et al., 2016; Park et al., 2020). These analyses also found an enrichment of downregulated genes that encode centrosomal proteins which are causative of microcephaly (Marthiens et al., 2013).